Ensuiko Sugar Refining (2112) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative results for FY2026 Q3 showed higher revenue and profit, although the growth in net income was primarily attributable to a temporary boost from gains on the sale of investment securities. Revenue was ¥25.23B (+0.8% YoY), Operating Income was ¥2.41B (+0.4%), and Ordinary Income was ¥2.60B (+1.7%). Net Income increased substantially to ¥2.22B, up +24.7% YoY; however, this figure includes ¥0.60B in extraordinary income (gain on sale of investment securities), and the rate of profit growth at the operating level was limited.

Factors Affecting Performance

【Revenue】Revenue was ¥25.23B, representing a modest increase of +0.8% YoY. The core Sugar Business generated ¥23.98B (95.0% of total, +1.0% YoY), while the Bio Business generated ¥1.26B (5.0% of total, -1.8% YoY). Growth in the Sugar Business drove overall performance, while the Bio Business recorded a decline in revenue.

【Profit and Loss】Operating Income was ¥2.41B (+0.4% YoY), indicating sluggish profit growth relative to revenue growth and weak operating leverage. The gross margin of 19.8% was broadly unchanged from the same period of the previous year, while the persistently high cost-of-sales ratio of 80.2% constrained improvement in profitability. Ordinary Income was ¥2.60B (+1.7% YoY), supported by non-operating income, including ¥0.19B in dividends received. Net Income was ¥2.22B (+24.7% YoY); however, extraordinary income of ¥0.60B (gain on sale of investment securities) accounted for approximately 18.9% of Profit Before Tax of ¥3.20B, indicating that the primary driver of the increase in net income was temporary. In conclusion, the core business achieved higher revenue and profit, but the rate of profit growth was modest, while the substantial increase in net income depended on a temporary factor.

Segment Analysis

The Sugar Business generated Revenue of ¥23.98B (95.0% of total, +1.0% YoY) and segment profit of ¥3.24B (+5.9% YoY). Its profit margin of 13.5% exceeded the company-wide Operating Income margin of 9.5%, making it the core earnings contributor. The Bio Business generated Revenue of ¥1.26B (-1.8% YoY) and segment profit of ¥0.24B (-11.9% YoY). Although its profit margin was high at 19.3%, the business continues to contract in scale. Against total segment profit of ¥3.54B, adjustments for general and administrative expenses, research and development expenses, and other items not attributable to reportable segments amounted to a negative ¥1.13B, reducing Operating Income to ¥2.41B. The Sugar Business’s pricing power and cost management will be key factors determining future earnings trends.

Key Financial Metrics

【Profitability】The Operating Income margin was 9.5% and the Net Income margin was 8.8%. The gross margin of 19.8% reflects high raw-material and manufacturing costs and indicates the structural characteristics of a commodity-oriented business.【Cash Quality】Net Income of ¥2.22B includes ¥0.60B in gains on the sale of investment securities, and it should be noted that profitability is therefore overstated as a measure of recurring earnings power.【Investment Efficiency】ROE of 11.4% was generated by a combination of an 8.8% Net Income margin, total asset turnover of 0.808x, and financial leverage of 1.60x, indicating a structure that is not excessively dependent on financial leverage.【Financial Soundness】The Equity Ratio was 62.5% (improved from 56.5% in the previous year), the current ratio was 123.8%, the quick ratio was 106.6%, and interest coverage was 32.1x. The capital structure and interest-payment capacity are conservative, although the short-term debt ratio of 45.3% warrants attention in connection with the refinancing of short-term borrowings.

Cash Flow Analysis

As cash flow statement figures have not been disclosed, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥2.70B, down from ¥3.31B in the previous year. Given the year-on-year increases in property, plant and equipment and investment securities, funds may have been increasingly allocated to investment activities. Based on accounts receivable of ¥2.36B, inventories of ¥1.25B, and accounts payable of ¥1.30B, the company has a structure in which changes in working capital can readily affect cash management. Since Net Income of ¥2.22B includes ¥0.60B in gains on the sale of investment securities, there may be a certain divergence between accounting profit and actual cash-generation capacity.

Quality of Earnings

The increase in profit for the current period depended more heavily on temporary factors than on recurring business activities. While Ordinary Income of ¥2.60B increased moderately by +1.7% YoY, Net Income rose substantially by +24.7%, with the difference explained by extraordinary income of ¥0.60B (gain on sale of investment securities). This extraordinary income accounted for approximately 18.9% of Profit Before Tax of ¥3.20B and should be excluded when assessing the quality of current-period net income. Dividends received of ¥0.19B accounted for the majority of non-operating income of ¥0.27B, with stable income from investment securities supporting Ordinary Income. Meanwhile, comprehensive income was ¥3.31B, exceeding Net Income of ¥2.22B. The difference was attributable to an ¥1.10B increase in valuation difference on securities, which is also subject to market fluctuations.

Earnings Forecast and Guidance

The full-year forecast assumes lower revenue and profit, with Revenue of ¥32.20B (-1.0% versus the previous fiscal year), Operating Income of ¥2.50B (-13.2%), and Ordinary Income of ¥2.80B (-8.3%). The Q3 cumulative progress rates were 78.4% for Revenue, 96.4% for Operating Income, and 92.9% for Ordinary Income, with profit progress substantially exceeding the standard 75% level. However, the 92.5% progress rate against the full-year Net Income forecast of ¥2.40B includes gains on the sale of investment securities. It is therefore inappropriate to judge the likelihood of exceeding the full-year forecast based solely on recurring earnings power. Trends in raw-material costs and sales volume in Q4 will determine consistency with the company’s plan, which appears conservative.

Shareholder Returns

The interim dividend was ¥0, and the full-year dividend forecast is ¥20 per share. Assuming forecast full-year Net Income of ¥2.40B and an estimated 27.52M shares outstanding, total dividends are calculated at approximately ¥0.55B, resulting in an estimated Payout Ratio of approximately 22.9%, a sustainable level. Retained earnings were substantial at ¥17.46B, indicating considerable dividend capacity from internal reserves. The amount of share repurchases has not been disclosed, and the Total Return Ratio has not been calculated.

Risk Factors

1. Low gross-margin structure and pricing power: The gross margin of 19.8% is below the general level for the food industry (25%–40%). If increases in raw sugar, energy, and logistics costs cannot be passed on through pricing, the Operating Income margin may decline further.

2. Refinancing risk for short-term debt: With a short-term debt ratio of 45.3%, changes in refinancing terms and the interest-rate environment, including ¥2.40B in short-term borrowings, could affect funding costs.

3. Dependence on investment securities: Investment securities totaled ¥10.59B, accounting for 33.9% of total assets, and current-period Net Income includes ¥0.60B in gains on sales. Market fluctuations and the timing of sales may create volatility in Net Income and comprehensive income.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

Both the company’s Operating Income margin and Net Income margin exceed the industry median, placing its profitability relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate is below the industry median, indicating that top-line growth is relatively modest within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The Q3 cumulative Operating Income progress rate was 96.4%, a high level relative to the full-year forecast. However, since the 92.5% Net Income progress rate includes ¥0.60B in gains on the sale of investment securities, recurring earnings progress needs to be evaluated separately.

2. The Sugar Business (95.0% of total) is the core earnings contributor, and its segment profit margin of 13.5% exceeds the company-wide level. The business’s pricing power and raw-material cost management are the primary drivers of performance trends.

3. The Equity Ratio improved to 62.5% (56.5% in the previous year), and interest-payment capacity remains robust, with interest coverage of 32.1x. Meanwhile, the structurally low gross margin of 19.8% and the short-term debt ratio of 45.3% remain points for ongoing monitoring.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 results were operationally steady, while reported net income growth was principally driven by a large gain on the sale of investment securities. Revenue increased 0.8% year on year to ¥25.23bn. Operating income rose 0.4% to ¥2.41bn, indicating that core profit growth broadly tracked the modest top-line expansion. Ordinary income grew 1.7% to ¥2.60bn, supported by dividend income of ¥0.20bn and interest income of ¥0.03bn. Gross profit increased 3.4% to ¥4.99bn. The gross margin improved by 49bp year on year to 19.8%, although it remains below the 20% quality-alert threshold and below typical food-industry benchmarks. The operating margin was essentially unchanged at 9.5%, with the 4bp expansion in gross margin largely absorbed by a 6.5% increase in SG&A expenses to ¥2.58bn. Net income increased 24.7% to ¥2.22bn, and EPS rose to ¥80.79 from ¥64.94. However, pre-tax income included a ¥0.61bn gain on sale of securities, compared with only ¥0.02bn in the prior-year period. Excluding the net ¥0.60bn extraordinary gain, pre-tax profit was approximately ¥2.60bn, broadly flat year on year. Comprehensive income rose 29.3% to ¥3.31bn, additionally supported by a ¥1.10bn valuation gain on securities recorded in OCI. The balance sheet strengthened, with equity increasing 17.6% year on year to ¥19.54bn and interest-bearing debt declining 19.2% to ¥5.30bn. Liquidity remains adequate, as current assets exceed current liabilities and the quick ratio is above 1.0x. Full-year operating-income progress has reached 96.4% against a standard Q3 benchmark of 75%, while net-income progress is 92.5%; this positioning implies limited required Q4 earnings but also reflects the non-recurring securities gain already booked. The earnings profile therefore combines resilient sugar operations, weaker bio earnings, a low-margin commodity-sensitive business model, and material reliance on investment-income and securities-related gains for above-core reported profit growth.

Profitability Analysis

The reported annualized ROE is 15.2%, comprising an 8.8% net profit margin, 1.077x annualized asset turnover, and 1.60x financial leverage. The largest contributor to the current reported ROE level is the net margin, but that margin is elevated by the ¥0.61bn gain on sale of securities rather than by a material improvement in operating profitability. Financial leverage is moderate, with D/E at 0.60x, so the return profile is not dependent on aggressive balance-sheet leverage. The annualized asset-turnover component is reasonable for a capital-intensive sugar producer, although 71.1% of assets are non-current and investment securities alone represent 33.9% of total assets. Gross margin expanded to 19.8% from 19.3%, but remains structurally low for food and beverage benchmarks, reflecting substantial cost-of-sales intensity: COGS represented 80.2% of revenue. Operating margin was stable at 9.5%, which remains solid on the stated general profitability benchmark but is not showing meaningful operating leverage. SG&A grew 6.5%, substantially faster than revenue growth of 0.8%, reducing the conversion of improved gross profit into operating-income growth. The segment-profit reconciliation also shows corporate and R&D cost adjustments widening 14.1% to negative ¥1.13bn. Interest coverage of 32.12x is strong, and the 1.329 interest-burden factor indicates that non-operating income more than offset financing costs. The 30.6% effective tax rate is broadly normal, with a tax burden of 0.694. Sustainable profitability should be assessed primarily through operating and ordinary income, which grew only 0.4% and 1.7%, respectively, rather than through the 24.7% net-income increase.

Growth Assessment

Revenue growth was modest at 0.8%, indicating limited consolidated volume and/or pricing expansion through the first nine months. The sugar business is the core operation, contributing ¥23.92bn of external sales, or approximately 94.8% of consolidated revenue. Sugar-business revenue increased 1.0% year on year and segment profit increased 5.9% to ¥3.24bn; its segment margin improved to 13.5% from 12.9%. This suggests modestly better gross-profit capture within the principal business despite the group-level low gross-margin structure. Bio-business revenue declined 1.8% to ¥1.22bn, while segment profit fell 11.9% to ¥0.24bn. Bio's segment margin remained higher than sugar's at 19.3%, but the decline in both sales and profit makes it a near-term drag on portfolio growth. Other-business external revenue increased to ¥0.09bn from ¥0.09bn and segment profit was broadly stable at ¥0.06bn. The full-year revenue forecast is ¥32.20bn, representing a 78.4% Q3 progress rate versus the standard 75% pace. The company needs ¥6.97bn of Q4 revenue to attain the full-year target, which is consistent with a normal quarterly run-rate. Operating-income progress is 96.4% against the ¥2.50bn forecast, 21.4 percentage points above the standard Q3 benchmark. Ordinary-income progress is 92.9%, also 17.9 percentage points above the standard pace. Full-year guidance nevertheless calls for operating income to decline 13.2% and ordinary income to decline 8.3% year on year, implying a sharply lower Q4 operating-profit contribution of approximately ¥0.09bn. Reported net-income progress is 92.5% against the ¥2.40bn forecast, but this is materially assisted by the non-recurring securities-sale gain. Revenue sustainability remains exposed to raw-material and sugar-market conditions, energy and logistics costs, exchange rates for imported inputs, consumer demand, and competition from private-label products.

Financial Health

Financial health is sound overall, supported by a 62.5% equity ratio, ¥19.54bn of equity, and total liabilities of ¥11.70bn. Total equity increased ¥2.93bn, or 17.6%, year on year, exceeding the ¥1.84bn, or 6.3%, increase in total assets. Interest-bearing debt declined ¥1.26bn year on year to ¥5.30bn, comprising ¥2.40bn of short-term loans and ¥2.90bn of long-term loans. The D/E ratio of 0.60x and debt-to-capital ratio of 21.3% are conservative and well within stated credit benchmarks. Interest coverage of 32.12x provides a substantial earnings buffer against current financing costs. The current ratio is 123.8%, above 1.0x, and working capital is positive at ¥1.74bn; accordingly, there is no immediate current-liability coverage warning. The quick ratio of 106.6% indicates that liquid current assets excluding inventory exceed current liabilities. The refinancing-risk quality alert remains relevant because short-term loans account for 45.3% of reported interest-bearing debt, above the 40% alert level. In addition, the current portion of long-term loans is ¥1.67bn, so contractual debt maturing within one year is larger than short-term loans alone. Cash and deposits of ¥2.70bn cover reported short-term loans by 1.12x, but do not fully cover short-term loans plus the current portion of long-term loans. This creates a manageable maturity mismatch rather than a solvency concern, since current assets total ¥9.03bn against current liabilities of ¥7.29bn and long-term debt capacity remains available. Investment securities increased ¥2.22bn, or 26.5%, to ¥10.60bn and represent 33.9% of total assets. This concentration strengthens financial asset value but increases exposure to market-price movements and makes equity and comprehensive income sensitive to securities valuations. Deferred tax liabilities of ¥1.20bn, versus deferred tax assets of ¥0.27bn, are consistent with the sizable unrealized valuation gains in the securities portfolio. Intangible assets are immaterial at 0.1% of assets, with no meaningful goodwill-related balance-sheet risk evident.

Notable B/S Changes

Investment securities: +¥2.22bn (+26.5%) to ¥10.60bn — now 33.9% of total assets; the increase and associated ¥1.10bn OCI valuation gain increase sensitivity of equity and comprehensive income to securities-market movements. Interest-bearing debt: -¥1.26bn (-19.2%) to ¥5.30bn — deleveraging improved D/E to 0.60x and strengthened solvency, although 45.3% remains in short-term loans. Total equity: +¥2.93bn (+17.6%) to ¥19.54bn — driven by retained-profit accumulation and higher accumulated OCI, materially improving the equity ratio to 62.5%. Current assets: -¥0.73bn (-7.4%) to ¥9.03bn — primarily alongside lower cash and inventories, while current liabilities declined more sharply by ¥0.65bn, preserving positive working capital.

Cash Flow Quality

Dividend Sustainability

The full-year DPS forecast is ¥20.00, while Q2 DPS was ¥0. Based on forecast EPS of ¥87.53, the implied dividend-only payout ratio is 22.8%, which is conservative relative to the 60% sustainability benchmark. The forecast dividend equates to approximately ¥0.55bn using average shares outstanding, leaving a substantial portion of forecast earnings retained. Retained earnings increased 11.5% year on year to ¥17.46bn, providing a strong accumulated capital base. The modest payout ratio and low-to-moderate leverage support financial flexibility. Dividend capacity should nevertheless be assessed against recurring earnings because FY2026 Q3 reported profit includes a ¥0.61bn securities-sale gain. The absence of an interim dividend indicates that the indicated annual distribution is likely weighted to the year-end payment.

Risk Assessment

Business risks include Commodity and procurement risk: the 19.8% gross margin and 80.2% COGS ratio leave earnings sensitive to sugar and other input costs, energy, packaging, freight costs, and foreign-exchange movements on imported materials., Pricing-power risk: revenue grew only 0.8%, and maintaining margin improvement depends on the ability to pass higher procurement and logistics costs through to customers., Sugar-business concentration: the sugar business accounts for approximately 94.8% of external revenue, concentrating exposure to domestic demand, industry supply-demand conditions, and policy or trade changes affecting sugar., Bio-business execution risk: bio revenue declined 1.8% and segment profit declined 11.9%, despite its higher segment margin than sugar., Food-industry risk: food safety incidents, product recalls, labeling or additive regulation, climate-related agricultural supply disruptions, and private-brand competition can affect demand and costs..

Financial risks include Refinancing risk: short-term loans represent 45.3% of interest-bearing debt, above the 40% quality-alert threshold; the current portion of long-term loans adds to near-term funding requirements., Securities-market risk: investment securities are ¥10.60bn, or 33.9% of assets, and valuation gains on securities added ¥1.10bn to OCI during the period., Earnings-volatility risk: the ¥0.61bn gain on sale of securities represented approximately 18.9% of pre-tax income and materially lifted net-income growth., Interest-rate risk is currently contained by 32.12x interest coverage and a 0.60x D/E ratio, but could increase if short-term funding costs rise..

Key concerns include LOW_GROSS_MARGIN alert: the 19.8% gross margin is below 20% and below normal food-industry benchmarks, evidencing a commodity-exposed and cost-sensitive operating model. The 49bp year-on-year improvement is constructive, but the margin remains thin relative to potential input-cost volatility., REFINANCING_RISK alert: the 45.3% short-term debt ratio points to a relatively front-loaded debt maturity profile. Liquidity is currently adequate, but continued refinancing access and funding-cost discipline remain relevant., Core operating-income growth was only 0.4%, while SG&A rose 6.5%; operating leverage has not yet emerged despite the gross-margin improvement., Full-year net-income achievement is heavily supported by non-recurring securities gains, reducing the comparability of the reported 24.7% net-income growth rate..

Investment Implications

Key takeaways include Core sugar operations showed modest revenue growth and improved segment profitability, but consolidated operating income was broadly flat., Reported net-income growth substantially exceeds underlying ordinary-income growth because of the ¥0.61bn gain on sale of investment securities., The balance sheet is conservatively capitalized, with a 62.5% equity ratio, 0.60x D/E, 21.3% debt-to-capital, and strong interest coverage., Investment securities are a material source of both financial strength and earnings/equity volatility., Forecast achievement rates are ahead of a normal Q3 pace, especially for operating profit, implying that management's full-year plan anticipates a very low Q4 operating-profit contribution..

Metrics to watch include Sugar-business revenue, segment margin, and the ability to preserve gross-margin gains, Bio-business sales and segment-profit recovery, SG&A growth relative to revenue growth and the scale of corporate/R&D cost adjustments, Gross margin and COGS ratio amid sugar, energy, packaging, logistics, and currency movements, Short-term borrowing, current maturities of long-term loans, refinancing terms, and interest expense, Investment-securities balance, realized disposal gains, and unrealized valuation changes, Q4 operating income relative to the approximately ¥0.09bn implied by full-year guidance.

Regarding relative positioning, The company combines a defensively capitalized balance sheet and strong interest coverage with a lower-than-typical food-industry gross margin and high exposure to commodity costs. Its operating margin is solid in absolute terms, but earnings quality is less robust than the headline net-income growth suggests because financial-asset gains are material. The large securities portfolio differentiates the capital structure from a pure operating food manufacturer, adding both asset backing and market-related earnings volatility.